Skip Navigation


Through strategic licensing-in partnership, we also offer patients with more affordable biosimilar products

To ensure more affordable access to quality medication for patients, we also work with our partners to broaden our portfolio by licensing in biosimilar products. Biosimilars are biological medicinal products that are similar to another biological product that has already been authorized and which do not differ significantly from the original product in terms of quality safety and efficacy. Our biosimilar portfolio is not only complementary to existing generic products but also offers more alternatives to fulfill different medication needs.